Raymond James Financial Services Advisors Inc. Has $1.08 Million Holdings in Teleflex Incorporated (NYSE:TFX)

Raymond James Financial Services Advisors Inc. decreased its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 45.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,325 shares of the medical technology company's stock after selling 3,624 shares during the quarter. Raymond James Financial Services Advisors Inc.'s holdings in Teleflex were worth $1,078,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Cambridge Investment Research Advisors Inc. lifted its stake in Teleflex by 2.5% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 2,231 shares of the medical technology company's stock worth $792,000 after purchasing an additional 54 shares in the last quarter. HighTower Advisors LLC lifted its stake in Teleflex by 2.2% in the 1st quarter. HighTower Advisors LLC now owns 4,678 shares of the medical technology company's stock worth $1,655,000 after purchasing an additional 99 shares in the last quarter. Private Advisor Group LLC purchased a new stake in Teleflex in the 1st quarter worth $455,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in Teleflex by 6.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,268 shares of the medical technology company's stock worth $2,224,000 after purchasing an additional 388 shares in the last quarter. Finally, Yousif Capital Management LLC lifted its stake in Teleflex by 2.7% in the 1st quarter. Yousif Capital Management LLC now owns 7,158 shares of the medical technology company's stock worth $2,540,000 after purchasing an additional 190 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Teleflex Trading Down 1.8 %

NYSE:TFX traded down $3.78 during mid-day trading on Monday, hitting $210.66. 275,393 shares of the stock traded hands, compared to its average volume of 260,367. The stock has a market capitalization of $9.92 billion, a price-to-earnings ratio of 27.98, a PEG ratio of 2.05 and a beta of 1.11. Teleflex Incorporated has a 52 week low of $177.63 and a 52 week high of $276.43. The firm's 50 day moving average is $228.97 and its two-hundred day moving average is $225.23. The company has a quick ratio of 1.29, a current ratio of 2.32 and a debt-to-equity ratio of 0.39.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, topping analysts' consensus estimates of $3.26 by $0.12. The business had revenue of $773.90 million for the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.52 EPS. On average, equities research analysts predict that Teleflex Incorporated will post 13.73 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were paid a $0.34 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 dividend on an annualized basis and a yield of 0.65%. Teleflex's dividend payout ratio is currently 18.06%.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares in the company, valued at $2,261,250. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 1.43% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on TFX. Truist Financial decreased their price target on shares of Teleflex from $270.00 to $265.00 and set a "hold" rating on the stock in a research note on Friday, February 23rd. Royal Bank of Canada decreased their target price on shares of Teleflex from $272.00 to $265.00 and set an "outperform" rating on the stock in a research report on Friday, February 23rd. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 23rd. JMP Securities restated a "market outperform" rating and set a $285.00 target price on shares of Teleflex in a research report on Friday, February 23rd. Finally, Raymond James upped their target price on shares of Teleflex from $227.00 to $271.00 and gave the company an "outperform" rating in a research report on Wednesday, December 20th. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $265.56.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.